Aspire Biopharma Holdings (ASBP) Current Assets (2021 - 2026)

Aspire Biopharma Holdings (ASBP) has reported Current Assets for 6 consecutive years, with $13.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets rose 1260.95% year-over-year to $13.5 million in Q2 2026; TTM through Jun 2026 was $13.5 million, a 1260.95% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 786.66% from the prior year.
• Current Assets was $13.5 million for Q2 2026 at Aspire Biopharma Holdings, up from $7.1 million in the prior quarter.
• Over five years, Current Assets peaked at $13.5 million in Q2 2026 and troughed at $65577.0 in Q1 2024.
• A 5-year average of $2.0 million and a median of $1.1 million in 2022 frame the typical range for Current Assets.
• Across the five-year window, Current Assets plunged 92.77% in 2024 and soared 2897.26% in 2025, its largest moves.
• Over 5 years, Current Assets stood at $1.1 million in 2022, then tumbled by 92.6% to $81223.0 in 2023, then soared by 82.2% to $147989.0 in 2024, then soared by 786.66% to $1.3 million in 2025, then soared by 926.21% to $13.5 million in 2026.
• The last three Current Assets figures came in at $13.5 million (Q2 2026), $7.1 million (Q1 2026), and $1.3 million (Q4 2025), per Business Quant data.